The Valley Hospital in Ridgewood, N.J., is one of 15 U.S. sites currently enrolling patients in a research study evaluating a potential new treatment for patients with symptomatic persistent and long standing persistent atrial fibrillation (AFib).

Bioengineers and physicians at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs. The new therapy could prevent or limit amputations for a condition that affects more than 27 million people and is a manifestation of advanced peripheral arterial disease.

A team of researchers led by the University of Missouri School of Medicine has developed a new, real-time method of imaging molecular events after ischemic strokes ― a finding that may lead to improved care for patients.

While there are constant advances in cardiac technologies, it is rare when one of these new ideas may rapidly challenge the standard of care in a very short period of time.

Abbott, Absorb bioresorbable stent, BVS, FDA advisory panel approval

An independent panel of experts convened by the U.S. Food and Drug Administration (FDA) voted 9 to 0, with one abstention, that the benefits of Abbott's Absorb fully bioresorbable drug eluting coronary stent outweigh the risks. The device will now go to the FDA for a final decision on market approval, likely later this year.

A new study from Juniper Research has estimated that the adoption of health monitoring devices will nearly treble by 2020, exceeding 70 million worldwide, up from an estimated 26 million this year.

People who reach their 80s without cardiovascular disease are more likely to suffer from the effects of dementia than a heart attack or stroke, according to a study in the Journal of the American College of Cardiology (JACC). In a small group of participants, an association was also found between zero or low levels of artery-clogging calcium deposits and a low risk of dementia and cardiovascular events, suggesting that the cardiovascular risk factors that lead to coronary heart disease could also affect the brain.

Dictum Health Inc. unveiled its Virtual Exam Room (VER), the centerpiece of its cloud-based, cybersecure and HIPAA-compliant telehealth system.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now